Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Share Option Plan

14 Mar 2006 07:05

Cello Group plc14 March 2006 Cello Group PLC("Cello") New Performance Share Option Plan Introduction Cello has adopted a new Performance Share Option Plan. The RemunerationCommittee of Cello recently carried out a review of the long term incentivearrangements for executive directors and other senior employees. Following thereview the Committee concluded that the existing arrangements should be replacedby a new Performance Share Option Plan. Background Cello previously operated two share option plans, the Enterprise ManagementIncentive Plan 2004 ("the EMI Plan") and the Cello Unapproved Share Option Plan2004 ("the Unapproved Plan"). Under these two plans ("the original share plans")options were granted with an exercise price equal to the market price at thegrant date. Following its review the Remuneration Committee concluded that, going forward,market value share option plans were not the most appropriate vehicles throughwhich Cello's senior executives should be granted long term incentives andaccordingly, under the new Plan, options will be structured as conditionalawards over fully paid shares with an exercise price equal to the nominal valueof the shares, currently 10p per share. As relatively ungeared investments,awards under the Plan will more closely match the returns received byshareholders than is the case with market value share options. In addition,these awards are likely to provide a closer correlation between actual rewardlevels and accounting charges going forward, as well as being less dilutive thanmarket value options. In addition, directors and eligible employees who elect to receive up to 50% ofcash bonuses, net of tax and national insurance, in the form of Cello shareswill be granted a conditional award over an equal number of shares under thePlan. Subject to the individual's continued employment by Cello and ownership ofthe shares issued in lieu of bonus, the matching shares will vest after fouryears subject to the performance conditions having been met. Principal provisions of the Plan Individual limits. Awards of options over shares, excluding bonus matchingshares, worth no more than 150% of basic salary may be made each year. Therewill also be a limit on the cumulative number of shares, excluding bonusmatching shares, which may be awarded to any individual over the life of thePlan. This limit has been set at 500,000 shares. Overall dilution limit. The Plan will be subject to the existing overalldilution limit which applied to the original share plans and was set out in theAdmission Document at the time of Cello's admission to AIM in November 2004.Therefore, in any ten year period from the date of adoption of the originalshare plans no more than 15% of the issued ordinary share capital of the companyfrom time to time may in aggregate be allocated under any share schemes operatedby the company. Performance conditions. Options will be exercisable four years after grantsubject to the extent to which a performance condition has been achieved overthe initial three year period after the award is made and subject to therecipient's remaining in Cello's employment for a further year. There will be noability to retest this condition and vesting will also be conditional uponearnings per share increasing in each of the three years after the date ofgrant. For any awards made in the first year following the implementation of thePlan the performance condition will be based on Cello's compound annual growthin earnings per share in the three years following the date of grant as shownbelow:- - no awards will vest if the CAGR is less than 10 per cent. - 20 per cent of awards will vest if the CAGR is 10 per cent. - 100 per cent of awards will vest if the CAGR is 15 per cent or more - if the CAGR is between 10 and 15 per cent. the percentage of awards vesting will be determined on a straight line basis between 20 and 100 per cent. Changes to performance conditions. The Remuneration Committee may applydifferent conditions for future awards and may also vary the performanceconditions applying to existing awards, for example, to take account oftechnical events such as changes in accounting standards and treatments.However, in both cases, the Committee will consult with Cello's majorshareholders before doing so. Change of control. On a change of control of the company (or, if the Committeedetermines, in the case of a demerger) options will be exercisable subject tothe extent to which the performance conditions have been satisfied up to thedate of the event (taking account of the fact that the conditions will bemeasured over a shorter period than originally envisaged). On a change ofcontrol that occurs as a result of an internal reorganisation, awards will berolled over (unless the Committee determines otherwise). Leavers. Options will normally lapse if a participant leaves the company.However, in certain "good leaver" situations (such as death, illness, disabilityetc.), or in other exceptional circumstances, options will either (i) beexercisable early subject to the extent to which the Committee determines thatthe performance conditions have been satisfied at the relevant time (againtaking account of the fact that the conditions will be measured over a shorterperiod than originally envisaged) or (ii) remain unaffected and vest at the endof the original four year period, in both cases with a pro rata reduction insize (unless the Committee waives the requirement to pro rate awards). Life of the Plan. The Plan will have a ten year life, although the Committeewill review it after no more than five years. Grants of awards The Remuneration Committee expects shortly to make the first awards under thePlan at which time a further announcement will be made. 14 March 2006 Enquiries:Cello Group PLC 020 7457 2020Kevin Steeds, Chairman College Hill 020 7457 2020Adrian Duffield/Ben Way This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Oct 20198:40 amRNSDisposal
18th Sep 20197:00 amRNSInterim Results
23rd Aug 201910:40 amRNSHolding(s) in Company
16th Aug 20197:00 amRNSAcquisition of ISS
6th Aug 20193:07 pmRNSTotal Voting Rights
6th Aug 20197:00 amRNSNotification of Half Year Results
18th Jul 20197:00 amRNSPre-close Trading Update
20th Jun 20194:29 pmRNSDirector/PDMR Shareholding
10th Jun 20199:41 amRNSTotal Voting Rights
24th May 201912:45 pmRNSBlock listing Interim Review
20th May 20194:29 pmRNSIssue of Equity
15th May 20197:00 amRNSHolding(s) in Company
8th May 20191:30 pmRNSResult of AGM
8th May 20197:00 amRNSAGM Statement
1st May 201912:15 pmRNSTotal Voting Rights
15th Apr 201911:12 amRNSAnnual Report and Notice of AGM
10th Apr 20197:00 amRNSCapital Markets Event
4th Apr 201910:00 amRNSTotal Voting Rights
27th Mar 20191:00 pmRNSHolding(s) in Company
21st Mar 20193:10 pmRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSPreliminary Results
6th Mar 20191:51 pmRNSHolding(s) in Company
7th Feb 20197:00 amRNSNotice of Full Year Results
17th Jan 20197:00 amRNSPre-Close Trading Statement
14th Dec 20189:24 amRNSBlock Listing Update
23rd Nov 20183:45 pmRNSHolding(s) in Company
19th Nov 20182:45 pmRNSHolding(s) in Company
12th Nov 201811:30 amRNSDirectorate Change
5th Nov 20182:00 pmRNSDirectorate Change
31st Oct 20183:30 pmRNSDirector/PDMR Shareholding
10th Oct 20187:00 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSAppointment of Executive Director
25th Sep 20181:00 pmRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSDirector/PDMR Shareholding
24th Sep 201811:39 amRNSTransfer of FTSE classification to Healthcare
21st Sep 201810:15 amRNSDirector/PDMR Shareholding
20th Sep 20184:00 pmRNSHolding(s) in Company
20th Sep 20187:00 amRNSDirector/PDMR Shareholding
19th Sep 20187:00 amRNSInterim Results
22nd Aug 20181:51 pmRNSHolding(s) in Company
17th Aug 20187:00 amRNSNotification of Half Year Results
16th Aug 20182:00 pmRNSTotal Voting Rights
16th Aug 20181:30 pmRNSBoard Changes
23rd Jul 20187:00 amRNSHolding(s) in Company
19th Jul 20187:00 amRNSPre-close Trading Update
17th Jul 20187:00 amRNSChange of registered office
4th Jul 20181:53 pmRNSHolding(s) in Company
27th Jun 201812:46 pmRNSHolding(s) in Company
22nd Jun 20184:47 pmRNSHolding(s) in Company
20th Jun 20182:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.